SEC inquiry
Executive Summary
Bristol "continues to believe that its accounting treatment of domestic wholesaler build-up has been completely appropriate," CEO Peter Dolan declares. The company specifically discussed its treatment of Medicaid accrual rates associated with the wholesaler inventory issues before recording a special charge for that amount in first quarter earnings, Dolan says (1"The Pink Sheet" April 29, p. 15)...